GlaxoSmithKline on Tuesday appointed Emma Walmsley, its head of consumer healthcare, to lead the British drugs giant and develop new treatments in a fast-consolidating sector.
Walmsley, 47, succeeds outgoing chief executive Andrew Witty, who is retiring early next year after almost a decade at...
ProfRem
Thread
drugs company
emma walmsley
glaxosmithkline
philiphampton
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.